Renal Volume in ADPKD Patient Evaluation.


Journal

International journal of nephrology
ISSN: 2090-214X
Titre abrégé: Int J Nephrol
Pays: United States
ID NLM: 101546753

Informations de publication

Date de publication:
2020
Historique:
received: 02 11 2019
revised: 09 01 2020
accepted: 24 01 2020
entrez: 12 3 2020
pubmed: 12 3 2020
medline: 12 3 2020
Statut: epublish

Résumé

The clinical manifestations of ADPKD are related to the growth of renal cysts. Renal volume has been recognised as the biomarker that is able to identify those patients at risk of complications (hypertension and haematuria) and at risk of progression to End Stage Renal Disease (ESRD). Recently, several scores have been introduced to predict the evolution of ADPKD. The Mayo Clinic Group developed a classification based on renal volume as measured by CT or MRI and corrected for age and height (Ht-TKV); this allowed predicting the evolution of the disease, but it has not been fully validated so far. In addition, it is used to identify patients labelled as "fast progressors" and eligible for Tolvaptan therapy according to the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) recommendations. We studied 80 patients who underwent MRI and had been classified as ADPKD typical form (class 1A-1E). A significant correlation between renal volume, hypertension, and low GFR was found (

Identifiants

pubmed: 32158561
doi: 10.1155/2020/9286728
pmc: PMC7060877
doi:

Types de publication

Journal Article

Langues

eng

Pagination

9286728

Informations de copyright

Copyright © 2020 M. Galliani et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

J Am Soc Nephrol. 2016 Mar;27(3):942-51
pubmed: 26150605
Nephrol Dial Transplant. 2018 Apr 1;33(4):563-573
pubmed: 29309655
Nephrol Dial Transplant. 2016 Mar;31(3):337-48
pubmed: 26908832
Am J Nephrol. 2018;48(1):67-78
pubmed: 30071518
Am J Nephrol. 2017;45(5):373-379
pubmed: 28315882
BMC Nephrol. 2017 Jul 17;18(1):241
pubmed: 28716055
N Engl J Med. 2006 May 18;354(20):2122-30
pubmed: 16707749
Kidney Int. 1983 Mar;23(3):526-9
pubmed: 6405076
Clin J Am Soc Nephrol. 2010 Aug;5(8):1471-9
pubmed: 20538839
J Am Soc Nephrol. 2015 Jan;26(1):160-72
pubmed: 24904092
Clin J Am Soc Nephrol. 2010 Jun;5(6):1091-8
pubmed: 20413443
PLoS One. 2017 Sep 29;12(9):e0185779
pubmed: 28961265
Clin J Am Soc Nephrol. 2012 Mar;7(3):479-86
pubmed: 22344503
Kidney Int Rep. 2017 Jan 16;2(3):442-450
pubmed: 29142971
Clin J Am Soc Nephrol. 2006 Jan;1(1):148-57
pubmed: 17699202
Am J Kidney Dis. 2016 May;67(5):792-810
pubmed: 26530876

Auteurs

M Galliani (M)

UOC Nefrologia, Dialisi e Litotrissia, Ospedale Sandro Pertini, Roma, Italy.

E Vitaliano (E)

UOC Nefrologia, Dialisi e Litotrissia, Ospedale Sandro Pertini, Roma, Italy.

S Chicca (S)

UOC Nefrologia, Dialisi e Litotrissia, Ospedale Sandro Pertini, Roma, Italy.

L Calvaruso (L)

UOC Nefrologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia, Università Cattolica del Sacro Cuore, Roma, Italy.

L Di Lullo (L)

UOC Nefrologia e Dialisi, Ospedale Delfino Prodi, Colleferro, Roma, Italy.

F Iorio (F)

UOC Diagnostica per Immagini, Ospedale Sandro Pertini, ASLRM2, Roma, Italy.

M E Tosti (ME)

National Center for Global Health, Istituto Superiore di Sanità, Roma, Italy.

A Paone (A)

UOC Nefrologia, Dialisi e Litotrissia, Ospedale Sandro Pertini, Roma, Italy.

Classifications MeSH